share_log

GE HealthCare Technologies Repeat Insider Selling Not A Positive Indicator

GE HealthCare Technologies Repeat Insider Selling Not A Positive Indicator

通用電氣醫療科技重複內幕拋售不是一個積極的指標
Simply Wall St ·  03/15 09:33

A number of GE HealthCare Technologies Inc. (NASDAQ:GEHC) insiders sold their shares in the last year, which may have raised concerns among investors. When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

去年,通用電氣醫療科技公司(納斯達克股票代碼:GEHC)的許多內部人士出售了股票,這可能引起了投資者的擔憂。在評估內幕交易時,了解內部人士是買入還是賣出通常更有利,因爲後者可能有多種解釋。但是,當多個內部人士在特定期限內出售股票時,股東應注意,因爲這可能是一個危險信號。

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

儘管我們認爲股東不應乾脆關注內幕交易,但我們認爲完全忽視內幕交易是愚蠢的。

The Last 12 Months Of Insider Transactions At GE HealthCare Technologies

通用電氣醫療科技公司過去 12 個月的內幕交易

The CEO of Ultrasound, Roland Rott, made the biggest insider sale in the last 12 months. That single transaction was for US$191k worth of shares at a price of US$77.37 each. So it's clear an insider wanted to take some cash off the table, even below the current price of US$88.33. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was 97% of Roland Rott's holding.

超聲波首席執行官羅蘭·羅特進行了過去12個月中最大規模的內幕交易。這筆單筆交易是價值19.1萬美元的股票,每股價格爲77.37美元。因此,很明顯,一位內部人士想從桌上提取一些現金,甚至低於目前的88.33美元。如果內部人士一直在賣出,特別是如果他們賣出低於當前價格,我們通常認爲這是負面的,因爲這意味着他們認爲較低的價格是合理的。但是,請注意,賣家可能有各種各樣的賣出原因,因此我們不確定他們對股價的看法。我們注意到,最大的單筆銷售是羅蘭·羅特持有的97%。

In the last year GE HealthCare Technologies insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

去年,通用電氣醫療科技內部人士沒有購買任何公司股票。下圖顯示了去年的內幕交易(公司和個人)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

insider-trading-volume
NasdaqGS:GEHC Insider Trading Volume March 15th 2024
納斯達克股票代碼:GEHC 內幕交易量 2024 年 3 月 15 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。

Insider Ownership Of GE HealthCare Technologies

通用電氣醫療科技的內部所有權

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. GE HealthCare Technologies insiders own about US$25m worth of shares. That equates to 0.06% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

測試公司領導者與其他股東之間一致性的另一種方法是查看他們擁有多少股份。較高的內部所有權通常會使公司領導層更加關注股東的利益。通用電氣醫療科技內部人士擁有價值約2500萬美元的股票。這相當於該公司的0.06%。這種內部所有權水平不錯,但還沒有特別突出。這無疑表明了一定程度的一致性。

So What Does This Data Suggest About GE HealthCare Technologies Insiders?

那麼,這些數據對通用電氣醫療科技內部人士有何啓示呢?

There haven't been any insider transactions in the last three months -- that doesn't mean much. Still, the insider transactions at GE HealthCare Technologies in the last 12 months are not very heartening. But we do like the fact that insiders own a fair chunk of the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. You'd be interested to know, that we found 2 warning signs for GE HealthCare Technologies and we suggest you have a look.

在過去的三個月中,沒有任何內幕交易——這並不意味着什麼。儘管如此,GE Healthcare Technologies在過去12個月中的內幕交易並不十分令人鼓舞。但是我們確實喜歡內部人士擁有公司相當一部分股份的事實。雖然我們喜歡了解內部人士的所有權和交易情況,但在做出任何投資決策之前,我們一定要考慮股票面臨的風險。你可能會有興趣知道,我們發現了GE Healthcare Technologies的兩個警告信號,我們建議你看看。

Of course GE HealthCare Technologies may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,通用電氣醫療科技可能不是最值得購買的股票。因此,您可能希望看到這個免費的高質量公司集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論